Asymptomatic and symptomatic urethral gonorrhoea in men who have sex with men attending a sexual health service  J.J. Ong, K. Fethers, B.P. Howden, C.K. Fairley, E.P.F. Chow, D.A. Williamson, I. Petalotis, E. Aung, K. Kanhutu, V. De Petra, M.Y. Chen  Clinical Microbiology and Infection  Volume 23, Issue 8, Pages 555-559 (August 2017) DOI: 10.1016/j.cmi.2017.02.020 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Mean interval (days) between last reported sexual contact with a male and onset of urethral symptoms. (1a) Men (78%, n = 189) with typical discharge treated for gonorrhoea (azithromycin 1 g plus ceftriaxone 500 mg) on the day of test; (2a) men (6%, n = 15) with other symptoms treated for gonorrhoea on the day of test; (2b) men (5%, n = 12) with other symptoms treated for non-gonococcal urethritis (azithromycin 1 g or doxycycline 100 mg twice daily for 7 days) on the day of test; (3a) men (3%, n = 6) with no symptoms treated for gonorrhoea on the day of the test because of reported contact with gonorrhoea; (3b) men (7%, n = 17) with no symptoms not treated for gonorrhoea on the day of test; (3c) men (1%, n = 3) with no symptoms on the day of test who developed typical discharge later. Clinical Microbiology and Infection 2017 23, 555-559DOI: (10.1016/j.cmi.2017.02.020) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Time intervals between last sexual contact and onset of urethritis symptoms among men who have sex with men with urethral gonorrhoea. Clinical Microbiology and Infection 2017 23, 555-559DOI: (10.1016/j.cmi.2017.02.020) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions